Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Baird Medical Investment Holdings (NAS:BDMD) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Baird Medical Investment Holdings's EV-to-EBIT for today is
Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-25.64 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Baird Medical Investment Holdings's EV-to-EBITDA for today is:
Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-24.53 Mil.
Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $22.54 Mil.
Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.34 Mil.
Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings Enterprise Value Related Terms
Baird Medical Investment Holdings Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings Enterprise Value Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Enterprise Value
0.00
0.00
0.00
212.23
60.80
Baird Medical Investment Holdings Semi-Annual Data
BDMD vs TELA, NSPR, PAVM: Enterprise Value Comparison
For the Medical Devices subindustry, Baird Medical Investment Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's Enterprise Value falls into.
Baird Medical Investment Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings (BDMD) has a Enterprise Value of $52.88 Mil as of Jul. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Baird Medical Investment Holdings and its competitors.
Is Baird Medical Investment Holdings' Enterprise Value too high?
Baird Medical Investment Holdings' current Enterprise Value is $52.88 Mil. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Enterprise Value compare to TELA and NSPR?
Baird Medical Investment Holdings' Enterprise Value of $52.88 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Enterprise Value is $52.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Enterprise Value of $52.88 Mil. The current Enterprise Value is $52.88 Mil. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Enterprise Value is $52.88 Mil as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Business Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
